Showing results (171-180 of 267) with videos related to

Sort By:
Pageof 27
Infection|January 4, 2001
Variation in antimicrobial utilization for febrile neutropenia in cancer patients. The CEMIC Study Group. Club d'Etudes des Maladies Infectieuses en CancerS Harbarth, M Viot, I Beeler, et al.
Drugs Under Experimental and Clinical Research|January 1, 1987
Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteriaP van der Auwera, A Vandermies, P Grenier, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patientsF Meunier, R Snoeck, H Lagast, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1983
Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infectionsJ Klastersky, L Coppens, P van der Auwera, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1986
BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteersA Pascual-Lopez, P Van der Auwera, S Lieppe, et al.
Chest|September 1, 1975
Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin-polymyxin B combinationJ Klastersky, C Hensgens, J Noterman, et al.
Anticancer Research|March 4, 2000
Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studiesT Berghmans, J Klastersky, E Markiewicz, et al.
Chest|May 1, 1979
Endotracheally administered antibiotics for gram-negative bronchopneumoniaJ Klastersky, F Carpentier-Meunier, L Kahan-Coppens, et al.
La Nouvelle Presse Medicale|March 27, 1982
[Clonogenic cultures of human tumours. Experience and prospects in cancer chemotherapy (author's transl)]M Rozencweig, O Makaroff, J M Prevost, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1988
Penetration of ciprofloxacin in bronchial secretions after intravenous administrationJ Berré, J P Thys, M Husson, et al.
Pageof 27